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The purpose of this study was to examine variations in endogenous oxytocin levels in
pregnancy and postpartum state. We also explored the associations between delivery
variables and oxytocin levels. A final sample of 272 mothers in their first trimester of preg-
nancy was included for the study. Blood samples were drawn during the first trimester and
third trimester of pregnancy and at 8 weeks postpartum. Socio-demographic data were
collected at each time point and medical files were consulted for delivery details. In most
women, levels of circulating oxytocin increased from the first to third trimester of preg-
nancy followed by a decrease in the postpartum period. Oxytocin levels varied considerably
between individuals, ranging from 50 pg/mL to over 2000 pg/mL. Parity was the main pre-
dictor of oxytocin levels in the third trimester of pregnancy and of oxytocin level changes
from the first to the third trimester of pregnancy. Oxytocin levels in the third trimester of
pregnancy predicted a self-reported negative labor experience and increased the chances
of having an epidural. Intrapartum exogenous oxytocin was positively associated with levels
of oxytocin during the postpartum period. Our exploratory results suggest that circulating
oxytocin levels during the third trimester of pregnancy may predict the type of labor a
woman will experience. More importantly, the quantity of intrapartum exogenous oxytocin
administered during labor predicted plasma oxytocin levels 2 months postpartum, suggest-
ing a possible long-term effect of this routine intervention, the consequences of which are
largely unknown.
Keywords: labor, oxytocin, pregnancy, epidural, syntocinon
INTRODUCTION
Pregnancy is a unique state that is accompanied by numerous bio-
logical and psychological changes. While there are known changes
in the levels of hormones such as progesterone and estrogen in
pregnant women (1), there is a paucity of information about vari-
ations in levels of oxytocin, crucial to parturition and lactation.
Oxytocin is a neuropeptide that is synthesized centrally in the
paraventricular and supraoptic nuclei of the hypothalamus and is
released into the bloodstream via the posterior pituitary during
labor, lactation, uterine dilatation, stress, after sexual stimulation,
and possibly during different types of social interactions (2–5).
Oxytocin is also released centrally in other parts of the brain (6)
and is synthesized peripherally in the ovary, testis, adrenal, thymus,
and pancreas (3).
In non-human primates, no reliable pattern of variation of
oxytocin during pregnancy or the postpartum period has been
observed, but a fourfold increase on the day of delivery has
been reported (7). A study in cows showed a similar peak of
plasma oxytocin levels on the day of delivery but very stable
and low levels of circulating oxytocin during the late pregnancy
period (8).
In humans, different methods for measuring oxytocin during
pregnancy and labor have been used including radioimmunoas-
say and enzyme immunoassay, and a variety of results have been
reported. Some studies have found that oxytocin levels increase
at the onset of labor and during labor compared to 1 or 2 weeks
before labor (9), reaching a peak just when the head of the baby is
delivered (10). More than two decades ago, Dawood (11) reviewed
the literature and concluded that plasma oxytocin levels increase
during pregnancy and parturition. de Geest and colleagues (12)
reported an increase of oxytocin levels with a maximum at term. In
another study, levels of oxytocin were found to increase slowly until
delivery and then decrease up to 8 weeks postpartum (13). One
group reported higher levels of oxytocin at 36 weeks of pregnancy
than 1 day after delivery or later (14). Another group observed
a steady increase in plasma levels of the oxytocin precursor,
neurophysin–oxytocin, during pregnancy followed by a decrease
between 7 and 42 days postpartum but stable plasma oxytocin lev-
els during pregnancy (15). In contrast, one team recently reported
no variations of oxytocin levels between the first trimester, the
third trimester, and the first month postpartum (16, 17). Fuchs
and Fuchs (1) noted that plasma levels of oxytocin can be difficult
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to measure because oxytocin has a half-life of a few minutes, is
found in low concentrations compared to other hormones, and is
released in a pulsatile pattern. These factors, as well as the dif-
ferences in experimental methodology, could explain the great
variation of results in the oxytocin literature.
Given the lack of clarity concerning oxytocin in pregnancy and
the postpartum period, the present longitudinal study aimed (a) to
describe the range of oxytocin levels in a larger sample of pregnant
women than had been studied hitherto; (b) to estimate plasma
oxytocin variations during pregnancy and the postpartum period;
and (c) to explore the relation between oxytocin levels and labor
outcomes. Thus, our main objective was to describe how plasma
oxytocin levels vary in a large cohort of pregnant women. Our
secondary interest was to raise, or confirm, hypotheses about oxy-
tocin correlates by exploring its association with a number of labor
variables available in our cohort.
MATERIALS AND METHODS
PARTICIPANTS
A total of 272 women were tested. We recruited 342 pregnant
women during their first trimester of pregnancy at an obstetrics
clinic in a general hospital (n= 245) and in a birthing center
(n= 97), in Montreal. Inclusion criteria were: pregnancy with
a single fetus; between 10 and 15 weeks of pregnancy; speaking
and reading either English or French. Exclusion criteria were:
younger than 18. Eleven women miscarried, 7 moved out of Mon-
treal, 32 dropped out (including 6 for health reasons), 6 were
excluded for health reasons, 13 had unreliable test results, and
1 was enrolled twice. Oxytocin levels were therefore obtained
at three time points in the final sample of 272 women: during
the first trimester (T1), the third trimester (T2), and 2 months
postpartum (T3).
PROCEDURE
The study was approved by the Jewish General Hospital Research
Ethics Committee and the Maison de Naissance Côtes des Neiges.
A recruiter approached women during their first prenatal visit or
during a general information session. Women meeting all of the
inclusion criteria and willing to take part in the study gave written
informed consent and were tested the same day. A second meet-
ing took place during their third trimester of pregnancy, and a
third meeting took place at the mothers’ homes 8 weeks postpar-
tum. At each meeting, women completed a series of questionnaires
described below in English or French, and blood samples (10 mL)
were then drawn by a nurse or a midwife. Women received $25
per visit. Blood samples were drawn between 9 a.m. and 5 p.m.,
as soon as the nurse was available or as soon as the meeting with
the doctor was over. At the postpartum session, if the mother was
breastfeeding or bottle-feeding when the research assistant and
nurse arrived, blood samples were drawn at least 30 min after the
completion of feeding. Data were collected between July 2009 and
September 2011.
DATA COLLECTION
Medical chart variables
Data were extracted from participants’ medical charts. Variables
included: length of pregnancy; use of an epidural anesthesia;
quantity of intrapartum exogenous oxytocin administered (for
induction or augmentation of labor), for mothers who gave birth
at the hospital; route of delivery (vaginal or cesarean); and dura-
tion of labor. The type of cesarean delivery was classified, according
to Lucas and colleagues’ definition (18), in one of four categories:
emergency, urgent, scheduled, and elective. Duration of labor was
calculated from the start of the active phase, defined as 3 cm
dilation and/or contraction every 3–5 min.
Socio-demographic variables
Data about age, education level, marital status, parity, and previ-
ous miscarriages were collected from a self-report questionnaire
completed by every participant at her first visit.
Somatization
Here, somatization is defined as the experience of physical symp-
toms most likely due to mental factors. One hypothesis is that
oxytocin might modulate the link between these mental factors
and their physical symptoms through its influence on the immune
system, observed in humans (19) and in animals (20, 21). We used
the 12 items of the somatization subscale of the SCL-90-R (22).
Participants had to rate the presence of various symptoms such as
headaches, soreness in muscles, heavy arms or legs, or dizziness on
a 5-point Likert scale (from “not at all” to “extremely”). This scale
has a good internal consistency (α= 0.86).
Experience of labor
An interview, conducted through phone at about 3 weeks postpar-
tum (mean= 26 days, SD= 15), evaluated whether the women
had a very negative, somewhat negative, neither negative nor
positive, somewhat positive, or very positive labor experience.
Breastfeeding
Since oxytocin is known to play a role in milk ejection during lacta-
tion (23), we asked mothers whether they were still breastfeeding at
2 months postpartum in order to explore whether plasma oxytocin
levels were associated with breastfeeding.
BLOOD SAMPLE ANALYSIS
Blood was collected from participants in a heparinized tube, stored
on ice until it could be centrifuged at 1600× g for 15 min at 4°C.
The plasma was frozen at −80°C. The samples were divided into
two aliquots. One was sent to the laboratory of Sue Carter, then at
the University of Illinois in Chicago for analysis; the second was
stored for future testing.
Oxytocin levels were measured using a commercially available
enzyme-linked immunosorbent assay (EIA: Enzo Life Sciences
Inc.). Direct measurement was performed following the manufac-
turer’s protocols and samples were diluted 1:2 or 1:4 as described
previously (24, 25). Samples were not extracted prior to analysis
and all samples were run in duplicate or triplicate. The minimum
detection limit for oxytocin was 15.6 pg/mL and inter and intra
assay coefficients of variability were less than 8.7%.
DATA ANALYSIS
We first compiled descriptive statistics for all variables collected
in the study, including means, standard deviations, medians, and
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inter-quartile ranges and proportions, as appropriate. We next cal-
culated correlation coefficients to examine, which variables were
associated with oxytocin,and with each other, to search for possible
confounding variables. All variables associated with oxytocin lev-
els were included in the models exploring the relationship between
oxytocin levels and labor or postpartum variables.
Three oxytocin measurements were taken for each participant.
It is important to note that previous research has suggested that
oxytocin levels measured in three repeated blood samples col-
lected from 65 participants at intervals of 5 min showed greater
inter-individual variation than intra-individual variation, with
an intraclass correlation coefficient suggesting modest reliability
(personal communication from Elizabeth Hoge). The intraclass
correlation coefficient indicates how much agreement there is
between two or more repeated measures. Even though this agree-
ment is moderate (26) in the case of oxytocin, it remains greater
than the variation between participants. As there was considerable
between-subject variability in the trajectories, we fit a Bayesian
random effects hierarchical model to these data. This model allows
individual-level estimation of each woman’s trajectory, while at
the same time estimating and summarizing overall trends across
women. At the first level of the hierarchical model, each woman’s
oxytocin values followed a piecewise linear regression model, with
distinct parameters for the slopes from time 1 to time 2 and from
time 2 to time 3. Therefore, for each woman i, i= I, 2, . . ., 272,
three parameters were estimated: an intercept αi representing the
baseline value at time 1, a first slope parameter β1i representing
the average change from time 1 to time 2, and a second slope β2i
representing the average change from time 2 to time 3. At the sec-
ond level of this model, the three parameters from the first level
are each assumed to follow normal densities across subjects. The
mean of each normal density represents the average parameter val-
ues across all women (average intercept and average slopes), while
the standard deviation of the normal distribution provides the
between-subject variability in the parameter values across women.
Finally, the third level of the hierarchical model placed diffuse prior
distributions across all parameters from the second level, ensuring
that the data drive all inferences.
Linear and logistic regression models were used to estimate
the best predictors of oxytocin levels at each time point, and
which outcomes oxytocin levels predicted. We included the fol-
lowing variables: parity, location of delivery, transfer from the
birth center to the hospital, epidural, duration of labor, categories
of cesarean birth, somatoform symptoms, positive experience of
labor, negative experience of labor, intrapartum exogenous oxy-
tocin administered, breastfeeding at 2 months postpartum, change
of oxytocin levels from the first to the third trimester, oxytocin
levels during the first trimester, during the third trimester, and
during the postpartum period. We ran several models, as displayed
in Table 3. The outcome variables were: levels of oxytocin at the
third trimester of pregnancy, oxytocin levels changes from first to
third trimester, labor duration, epidural, quantity of intrapartum
oxytocin administered, negative experience of labor, positive expe-
rience of labor, breastfeeding, and oxytocin levels at 2 months
postpartum. While several models including all the variables men-
tioned above were run for each outcome in order to investigate
possible confounding, we present only the model that includes
important predictors or confounders. This selection of models was
based on clinical judgment. As such, if the variable has no apprecia-
ble effect and was not a confounder, it was omitted, otherwise it was
included. More specifically, for each outcome estimated, we report
here in Table 3 only the model that was optimized to make future
predictions about the outcome. When oxytocin is the outcome,
all other variables excluding oxytocin levels were included. When
labor variables were estimated, all other variables and oxytocin
levels were included. It is worth noting that we did not correct our
confidence interval levels for multiple comparisons even though
we estimated many parameters. Due to the exploratory nature of
these analyses, we prefer not to risk eliminating any potential valid
result.
The longitudinal models were fit using WinBUGS software
(version 1.4.3, MRC Biostatistics Unit, Cambridge, UK). Other
models were run using R (version 2.12, R Development Core Team,
2012).
RESULTS
DESCRIPTIVE STATISTICS
Descriptive statistics are shown in Table 1. Most participants
were married or living with a partner; had a vaginal delivery;
had not experienced a previous miscarriage; and delivered around
39.6 weeks of gestation (SD= 1.3). Most were pregnant with their
first or second child. Seven women delivered pre-term, and one
baby did not survive. These women were later excluded from the
study. The mean gestational age was 11.9 weeks (SD= 2.1) at T1
and 32.5 weeks (SD= 2.0) at T2.
RANGE AND VARIATION OF OXYTOCIN LEVELS
Figure 1 shows that oxytocin levels varied considerably across
individuals (Min= 32.3 pg/mL; Max= 2297.6 pg/mL). The mean
oxytocin levels were 308.3 pg/mL (SD= 272.3) at T1; 396.5 pg/mL
(SD= 278.8) at T2; and 286.3 pg/mL (SD= 272.7) at T3. Intra-
individual mean variations from T1 to T2 were 88.1 pg/mL
(SD= 223.6) and from T1 to T3 were−22.1 pg/mL (SD= 170.3).
As there were no differences in oxytocin levels between centers
[mean difference T1:−10.5 pg/mL, CI= (−80.6; 59.5); mean dif-
ference T2:−16.1 pg/mL, CI= (−87.8, 55.5); mean difference T3:
44.6 pg/mL, CI= (−25.3, 114.5)], data are presented for the whole
group instead of by center.
Our hierarchical model estimated that oxytocin levels increased
from T1 to T2 [change of 0.60 pg/mL estimated per day,CI= (0.41;
0.79)] and decreased from T2 to T3 [change of −1.03 pg/mL esti-
mated per day, CI= (−1.30; −0.76)]. The standard deviations of
the slopes between T1 and T2 and between T2 and T3 were very
large [T1–T2: mean SD= 1.57, CI= (1.45; 1.71); T2–T3: mean
SD= 2.26, CI= (2.07; 2.46)]. This suggests that this pattern of
positive slope from T1 to T2 and negative slope from T2 to T3 was
not followed by all women. Indeed, as shown in Figure 2, 64.7%
of the mothers had rising oxytocin levels from T1 to T2 and falling
levels from T2 to T3 (group Rise–Fall); 8.5% had rising levels from
T1 to T2 as well as from T2 to T3 (group Rise–Rise); 15.4% had
falling levels from T1 to T2 and increasing levels from T2 to T3
(group Fall–Rise); and 11.4% had decreasing levels from T1 to T2
as well as T2 to T3 (group Fall–Fall).
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Table 1 | Descriptive statistics of the participants.
Mean (standard deviation)
Age (years) 31.6 (4.6)
Education (years) 15.3 (2.6)
Length of pregnancy (weeks, n=271) 39.6 (1.2)
Duration of labor (h, n=232) 8.6 (6.7)
Marital status (N =341) Percentage
Single 4.4
Married 68.0
Living with partner 25.4
Divorced/separated 2.2
Parity
0 47
1 38
2 10
3 or + 5
Type of delivery
Vaginal 74
Vaginal after cesarean birth 4
Elective cesarean birtha 9
Scheduled cesarean birtha 7
Urgent cesarean birtha 5
Emergency cesarean birtha 1
Miscarriage
0 71
1 24
2 or + 5
N= 272 unless otherwise specified.
aCesarean births are classified using Lucas et al.’s criteria (18).
RELATIONSHIP BETWEEN OXYTOCIN LEVELS AND LABOR OUTCOMES
The four groups defined above were compared for labor dura-
tion, somatoform symptoms, intrapartum exogenous oxytocin,
and experience of labor, parity, and route of delivery (Table 2).
Labor was shorter in the Fall–Rise group than in the Rise–Fall
or Rise–Rise groups [mean difference of 2.37 h, 95% CI= (0.73;
4.01) and of 4.23 h, CI= (0.76; 7.70), respectively]. The Fall–
Fall group experienced more somatoforms symptoms at time
2 than the Rise–Fall group [mean difference of 1.27, CI (0.29;
2.20)] and received more intrapartum exogenous oxytocin than
the Fall–Rise group [mean difference of 2.04 IU, CI= (0.08;
4.81)]. Finally, more mothers from the Fall–Rise group experi-
enced a very positive or somewhat positive labor than moth-
ers in the Fall–Fall or Rise–Fall groups [mean difference of
26.5%, CI= (6.7; 46.4) and of 15.2%, CI= (3.2; 27.2), respec-
tively].
To explore the associations between oxytocin levels and the
other variables, we ran a series of multivariate models, summarized
in Table 3 and described below.
Oxytocin levels at the third trimester of pregnancy and changes
of oxytocin levels from the first to third trimester of pregnancy,
were predicted by parity, with greater parity predicting lower oxy-
tocin and a smaller variation in oxytocin between the first and third
trimester. Postpartum oxytocin levels (T3) were predicted by the
quantity of intrapartum exogenous oxytocin received, with more
intrapartum oxytocin predicting higher plasma oxytocin levels at
2 months postpartum. There were no other significant predictors
of plasma oxytocin levels at T3.
A “very negative” or “somewhat negative” labor was predicted
by oxytocin at the third trimester, the type of cesarean delivery,
and the quantity of intrapartum oxytocin received. In contrast,
only intrapartum exogenous oxytocin and cesarean birth type
were relevant variables explaining positive labor scores. Having
an epidural was predicted by oxytocin levels at the first and third
trimester (or oxytocin changes from first to third trimester), the
birth location (hospital or midwife clinic), and the quantity of
intrapartum exogenous oxytocin received.
RELATIONSHIP BETWEEN OXYTOCIN AND BREASTFEEDING
Only 30 women had stopped breastfeeding at 2 months postpar-
tum. They stopped breastfeeding at around 7 weeks postpartum
(n= 13, data were not collected for the others mothers). Mean
postpartum oxytocin levels for the mothers who did not, or
had stopped, breastfeeding were 327.9 pg/mL (SD= 187.0), and
284.9 pg/mL (SD= 285.7) for the women who were still breast-
feeding. Using a Wilcoxon method, the mean estimated difference
between the two groups was 62.5 pg/mL [CI= (15.8; 117.1)].
Using a multivariate model to test, which variables predicted
breastfeeding, we found that oxytocin levels were not good predic-
tors of breastfeeding at T3. The only variable that was associated
with breastfeeding was location of delivery, as reported in Table 3.
Indeed, all the women who stopped breastfeeding gave birth at the
hospital.
DISCUSSION
We measured plasma oxytocin levels in healthy women at three
time points: during the first and third trimesters of pregnancy
and 2 months postpartum. There were large inter-individual dif-
ferences in oxytocin levels, with some women having less than
50 pg/mL and others having more than 2000 pg/mL (Figure 1).
For most women, oxytocin levels rose from the first to the third
trimester and fell during the postpartum period. These observa-
tions are in accordance with previous studies (12, 13). However,
one team has reported stable oxytocin levels across pregnancy and
1 month after delivery (16, 17). To the best of our knowledge, our
study is the first to investigate oxytocin levels during pregnancy in
a sample of this size.
Animal studies suggest that oxytocin levels rise as delivery
approaches, in part because oxytocin has a contractile function
on the uterine muscles (1), and its release is triggered by cervical
stimulation (27). In addition, the number of oxytocin recep-
tors increases dramatically in late pregnancy (28, 29). Based on
these findings, we expected oxytocin to rise during the course
of pregnancy, and indeed, 73.2% of women showed an increase
in oxytocin levels from the first to the third trimester. The mea-
surement obtained in the third trimester was close to the time of
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FIGURE 1 | Plasma oxytocin levels during the pregnancy and postpartum periods. Red crosses indicate mean values for each time period.
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FIGURE 2 | Plasma oxytocin levels in the four groups of women with different patterns of oxytocin level variations. Red crosses indicate mean values
for each time period.
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Table 2 | Descriptive statistics for each group of women according to their pattern of oxytocin level variation.
Continuous variables Rise–rise group Rise–fall group Fall–rise group Fall–fall group
N Mean SD N Mean SD N Mean SD N Mean SD
Labor duration (h) 18 10.51 6.48 153 8.65 5.24 32 6.28 3.96 26 9.29 7.01
Somatoform symptoms T1 23 4.96 3.08 176 5.28 2.80 42 4.81 2.17 31 5.61 2.69
Somatoform symptoms T2 23 5.74 2.77 175 5.73 2.67 40 6.50 2.74 31 6.97 2.39
Exogenous oxytocin (IU) 23 1.90 4.02 175 1.23 2.52 42 0.58 1.85 31 3.02 6.29
Dichotomous variables N Percentage N Percentage N Percentage N Percentage
Cesarean birth 23 13.0 175 5.1 42 4.8 31 6.5
Epidural 23 60.9 175 61.7 42 45.2 31 51.6
Negative experience labor 22 13.6 175 11.4 41 4.9 31 19.4
Positive experience labor 22 81.8 175 72.6 41 87.8 31 61.3
First child 23 43.5 176 51.1 42 66.7 31 48.4
T1=first trimester of pregnancy; T2= third trimester of pregnancy, T3=2 months postpartum. Rise–rise=oxytocin levels rise from T1 to T2 and from T2 to T3;
rise–fall=oxytocin levels rise from T1 to T2 and fall from T2 to T3; fall–rise=oxytocin levels fall from T1 to T2 and rise from T2 to T3; fall–fall= oxytocin levels fall from
T1 to T2 and from T2 to T3.
delivery and could reflect the preparation of the body for labor. In
animal studies, the rise observed occurs over a very short period
and is very close to the beginning of labor. Whether the same pat-
tern occurs in some humans cannot be determined by the present
study. The decrease observed after delivery was also expected as
the number of oxytocin receptors decreases in the uterus of post-
partum rats (30), suggesting that oxytocin is no longer playing the
same physiological role as at birth.
It is unclear why some authors have found stable levels across
pregnancy. As mentioned earlier, oxytocin has a very short half-
life and is found in comparatively low concentrations, which
makes it difficult to measure in blood (1). More importantly,
the pulsatile pattern of oxytocin release (31, 32) might explain
the variations from one study to another depending on when
blood was drawn. However, in two studies (33, 34) where blood
samples were taken two or three times and oxytocin levels aver-
aged to try and cancel this pulsatile effect, the variations across
participants remained very high, suggesting that this might not
be the source of the disparate results in the literature. The large
within-subject fluctuations of oxytocin levels from one time point
to the other might be partly due to random variation. Thus, a
possible limitation to the present study is some misclassifica-
tion of women into the four categories of oxytocin (Figure 2).
Finally, very little is known about factors that influence plasma
oxytocin levels. Another limitation of the present study is that
other variables might have affected oxytocin levels, such as moth-
ers’ stress, sexuality, environment, or medications. On a molecular
level, the amount of freely available oxytocin measured by the
antibody-based assay might vary due to the amount of albumin
circulating, a protein that is likely to bind oxytocin. As albumin lev-
els decrease as pregnancy progresses (35), more oxytocin becomes
available for the assay. This mechanism could explain how oxy-
tocin levels rise during pregnancy but also brings new factors
(those affecting albumin levels) into play. In parallel, in addi-
tion to its role in pregnancy, oxytocin has been shown to have
significant social functions both in animals and humans (36).
It is possible that oxytocin levels during the experimental visits
reflect in part the qualities of the social interactions that took
place with the research assistant and the nurse rather than birth
variables.
Concerning the relationship between oxytocin levels and the
other variables, it is important to keep in mind that all analy-
ses were exploratory and are thus to be considered carefully, as
they need to be replicated. In general, the women who were preg-
nant with their first child had higher oxytocin levels in the third
trimester and showed a larger increase in oxytocin levels from the
first to the third trimester compared to the mothers who already
had one or more children. Parity also predicted the duration of
labor as well as the quantity of intrapartum oxytocin adminis-
tered to the mothers. The association of parity with the length of
labor has long been known (37, 38). Presumably, the chances of
receiving intrapartum oxytocin to accelerate labor increase with
the length of labor.
While there was no direct association between oxytocin levels
and the duration of labor, the fact that first-time mothers under-
went a greater rise in oxytocin from the first to the third trimester
and exhibited higher levels of oxytocin in the third trimester may
have a functional significance. Oxytocin may mediate some of the
physiological changes that are required to give birth for the first
time, and these changes may leave the body permanently sensitized
to oxytocin. Subsequent pregnancies may thus require a smaller
increase in oxytocin.
Four additional findings emerge from this study. The first is
that both the increase in oxytocin levels from the first to the third
trimester, as well as the levels of oxytocin at both of those times,
predicted the probability of epidural use during delivery. The sec-
ond finding is that high oxytocin levels at the third trimester of
pregnancy predicted a negative experience of labor. Taken together,
these findings highlight the possibility of using oxytocin levels and
their variations to predict some of the features of labor.
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Table 3 | Relationship between oxytocin levels and the variables of interest.
VARIABLES PREDICTING OXYTOCIN LEVELS
Oxytocin changeT1 toT2 Parity
−33.853 (−59.345, −8.360)
OxytocinT2 Parity
−29.943 (−62.745, 2.860)
OxytocinT3 Exogenous oxytocin
15.592 (5.733, 25.452)
VARIABLES PREDICTING LABOR
Exogenous oxytocin Epidural Parity
1.787 (1.038, 2.535) −0.529 (−0.890, −0.168)
Labor duration Parity Center Exogenous oxytocin Transfer to hospital
−1.456 (−2.021, −0.891) −4.417 (−5.8525, −3.009) 0.598 (0.430, 0.766) 3.985 (1.990, 5.979)
Negative experience of labora Cesarean birth Exogenous oxytocin Oxytocin T2
17.813 (4.448, 71.336) 1.296 (1.132, 1.484) 1.002 (1.000, 1.003)
Positive experience of labora Cesarean birth Exogenous oxytocin
0.790 (0.701, 0.889) 0.081 (0.020, 0.323)
Epidurala Center Exogenous oxytocin Oxytocin T1 Oxytocin T2
0.116 (0.061, 0.223) 1.478 (1.198, 1.824) 0.997 (0.995, 0.999) 1.003 (1.001, 1.004)
Epidurala Center Exogenous oxytocin Oxytocin change T1 to T2
0.117 (0.061, 0.225) 1.456 (1.181, 1.795) 1.003 (1.001, 1.004)
VARIABLES PREDICTING BREASTFEEDINGATT3
Breastfeedinga Center
7.653 (1.778, 32.940)
Outcome (dependent variable) is indicated in bold. For each outcome, all other variables were included in the analyses and only the model optimized for future pre-
dictions about the outcome is reported. For continuous outcomes, the parameter estimates provide the change in outcome for a one unit change in the independent
variable, with 95% confidence interval in brackets. When the outcome is a dichotomous variable (indicated by a), we provide the odds ratio for a one unit change,
with the confidence interval in brackets. T1=first trimester of pregnancy, T2= third trimester of pregnancy, T3=2 months postpartum.
The third finding is that women who had stopped breast-
feeding when interviewed at 2 months postpartum had higher
oxytocin levels than those who were still breastfeeding. This result
is at odds with previous reports, where higher plasma oxytocin
levels were observed for breastfeeding women compared to non-
breastfeeding women (39, 40). It is important to note that only
slightly more than 10% of the mothers had stopped breastfeeding
at 2 months postpartum. Future studies with a large number of
non-breastfeeding mothers and investigating this specific question
could help reconcile our findings with those of previous reports.
The last finding is that the quantity of intrapartum exoge-
nous oxytocin administered just before delivery predicted oxytocin
levels at 2 months postpartum. This is contrary to Jonas and
colleagues’ findings (41) of a negative correlation between exoge-
nous oxytocin administered during labor and plasma oxytocin
levels 2 days postpartum during a breastfeeding session. How-
ever, their groups were small compared to those of the present
study, and plasma oxytocin was measured 2 days postpartum,
which makes our respective findings difficult to compare. In
addition, Jonas and colleagues included the quantity of oxytocin
administered after delivery in their analysis which we did not,
because of the unreliability of these data in our sample. In any
case, these findings suggest the presence of a long-term effect of
intrapartum exogenous oxytocin administration on endogenous
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circulating oxytocin levels. Little is known about other possi-
ble long-term effects of oxytocin administration during labor
on the physiology of the mother. A recent study (42), however,
has linked intrapartum exogenous oxytocin to difficulties with
sucking behavior in the newborn and a decreased duration of
breastfeeding. Given the role of oxytocin in lactation, the long-
term effect of exogenous oxytocin on endogenous oxytocin may
be relevant to explaining this finding. In addition, it remains
unknown whether exogenous oxytocin administered during labor
affects the fetus and, if so, how. Further, a number of studies have
shown that exogenous oxytocin produces significant psycholog-
ical effects, including improved self-perception (43), improved
perception of social relationships (44), decreased memory for
objects visually perceived (45), and significant physiological effects
including on the immune system (19). It is possible, therefore,
that exogenous oxytocin affects the psychological and physio-
logical states of the mother or, indeed, of the newborn. Many
women giving birth in North America receive intrapartum oxy-
tocin to induce or accelerate labor. Our finding of a direct asso-
ciation between exogenous oxytocin administered before delivery
and the levels of plasma oxytocin 2 months postpartum provide
evidence of a possible long-term effect of this routine interven-
tion, the consequences of which are largely unknown. Whether
oxytocin administration, either during labor or following deliv-
ery, has other physiological or psychological effects, and whether
those effects persist, are questions of some urgency for future
research.
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